Publications:

---

Identification and in silico analysis of noval alteration Arg420Gly in KIT proto oncogene among acute myeloid leukemia patients.

Scientific Reports

Akram, Afia Muhammad AM; Hassan, Mubashir M; Chaudhary, Asma A; Hayat, Sikandar S; Ali, Qurban Q; Hussain, Taha T; Zafar, Amjad A; Javed, Muhammad Arshad MA

Publication Date: 2022-11-10

Variant appearance in text: KIT: T417I

PubMed Link: 36357474

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Role and significance of c-KIT receptor tyrosine kinase in cancer: A review.

Bosnian Journal Of Basic Medical Sciences

Sheikh, Emana E; Tran, Tony T; Vranic, Semir S; Levy, Arkene A; Bonfil, R Daniel RD

Publication Date: 2022-09-16

Variant appearance in text: KIT: T417I

PubMed Link: 35490363

Variant Present in the following documents:

• BJBMS-22-683.pdf

View BVdb publication page

---

Molecular correlates and therapeutic targets in T cell-inflamed versus non-T cell-inflamed tumors across cancer types.

Genome Medicine

Bao, Riyue R; Stapor, Daniel D; Luke, Jason J JJ

Publication Date: 2020-10-27

Variant appearance in text: KIT: T417I

PubMed Link: 33106165

Variant Present in the following documents:

• 13073_2020_787_MOESM1_ESM.xlsx, sheet 9

View BVdb publication page

---

Heterogeneous prognosis among KIT mutation types in adult acute myeloid leukemia patients with t(8;21).

Blood Cancer Journal

Qin, Ya-Zhen YZ; Zhu, Hong-Hu HH; Jiang, Qian Q; Xu, Lan-Ping LP; Jiang, Hao H; Wang, Yu Y; Zhao, Xiao-Su XS; Liu, Yan-Rong YR; Zhang, Xiao-Hui XH; Liu, Kai-Yan KY; Huang, Xiao-Jun XJ

Publication Date: 2018-08-07

Variant appearance in text: KIT: T417I

PubMed Link: 30087318

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Distinct cellular properties of oncogenic KIT receptor tyrosine kinase mutants enable alternative courses of cancer cell inhibition.

Proceedings Of The National Academy Of Sciences Of The United States Of America

Shi, Xiarong X; Sousa, Leiliane P LP; Mandel-Bausch, Elizabeth M EM; Tome, Francisco F; Reshetnyak, Andrey V AV; Hadari, Yaron Y; Schlessinger, Joseph J; Lax, Irit I

Publication Date: 2016-08-16

Variant appearance in text: KIT: T417I

PubMed Link: 27482095

Variant Present in the following documents:

• Main text

View BVdb publication page

---

The strength and cooperativity of KIT ectodomain contacts determine normal ligand-dependent stimulation or oncogenic activation in cancer.

Molecular Cell

Reshetnyak, Andrey V AV; Opatowsky, Yarden Y; Boggon, Titus J TJ; Folta-Stogniew, Ewa E; Tome, Francisco F; Lax, Irit I; Schlessinger, Joseph J

Publication Date: 2015-01-08

Variant appearance in text: KIT: T417I

PubMed Link: 25544564

Variant Present in the following documents:

• Main text

View BVdb publication page

---